Figure 4From: Novel devices for individualized controlled inhalation can optimize aerosol therapy in efficacy, patient care and power of clinical trials Tobramycin detection by gamma camera in one of the study patients. A - Lung deposition of 37.2 mg tobramycin after inhalation of 160 mg Gernebcin® by means of the AKITA®; B - Lung deposition of 26.4 mg tobramycin after inhalation of 300 mg TOBI® by means of Pari LC Plus®.Back to article page